| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1600064 | 抗人肿瘤坏死因子-α单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2016-11-10 | 北京绿竹生物技术股份有限公司 | Beijing Lvzhu Biological Technology Co Ltd | Certificate Issued | 2017-11-21 | view |
| CXSL1400098 | 抗人肿瘤坏死因子-α单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2015-01-19 | 北京绿竹生物技术股份有限公司 | Beijing Lvzhu Biological Technology Co Ltd | Certificate Issued | 2016-05-12 | view |